Evaluation of professional practices in the use of mexiletine for the management of childhood myotonia in French pediatric neuromuscular centers (MEXI-PEDI survey)
Archives de Pédiatrie · 2025
DOI: 10.1016/j.arcped.2024.10.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives de Pédiatrie, 2025. Verfasst von Sarah Barrière und 29 weiteren Autor:innen. Beteiligte Einrichtung: CMR Neuromusculaire, Service de génétique médicale, Hôpital Estaing, CHU de Clermont-Ferrand, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Mexiletine, Pediatrics, Myotonia, Off-Label Use. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Myotonia is the main feature of both myotonic dystrophy (DM) and non-dystrophic myotonia (NDM). It is felt as stiffness, pain, fatigue, and weakness. In France, mexiletine, a non-selective voltage-gated sodium channel blocker, is approved for the treatment of myotonia in adults with NDM, and it has a temporary recommendation for use in the symptomatic treatment of DM in adults. However, it is not currently licensed for treating myotonia in children due to the lack of studies on its use in pediatrics. This has meant heterogeneous practices in its utilization and has led to prescriber reluctance, which has jeopardized accessibility. We undertook a professional practice survey of French pediatric neuromuscular centers to determine their prescribing habits for mexiletine, assessing indications, doses, efficacy, and tolerance. METHODS: One medical pediatric professional from each French pediatric neuromuscular center belonging to the national neuromuscular network (FILNEMUS) was invited to complete an anonymous questionnaire. RESULTS: In total, 34 healthcare professionals responded. Of these, 16 had already treated a child for myotonia with mexiletine. Mexiletine was prescribed in one third of pediatric patients with NDM, but it was used in only 3% of DM type 1 patients and in no DM type 2 patients. Pre-treatment assessment always included a cardiac evaluation; however, the method of introduction (inpatient vs. outpatient basis), dosage adjustment, and efficacy evaluation ranged widely. More than half of the respondents reported a high efficacy of mexiletine in their patients; only three reported moderate adverse events (dyspepsia, loss of appetite, and asthenia). CONCLUSION: The findings of this first survey on mexiletine for pediatric myotonia in France lend support for the creation of future national guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CMR Neuromusculaire, Service de génétique médicale, Hôpital Estaing, CHU de Clermont-Ferrand, Clermont-Ferrand, France.
- CMR Neuromusculaire, HFME, HCL, Bron, France.
- CMR Neuromusculaire, Hôpital Necker, APHP, Paris, France.
- CMR Neuromusculaire, Hôpital Cochin, APHP, Paris, France.
- CMR Neuromusculaire, Service de Neuropédiatrie, Hôpital Timone Enfants, Marseille, France.
- CMR Neuromusculaire, Hôpital des Enfants, CHU Toulouse, Toulouse, France.
Zitieren
APA
Barrière, S., Manel, V., Barnerias, C., Wahbi, K., Audic, F., Cances, C., Chouchane, M., Dabaj, I., Davion, J. B., Desguerre, I., Durigneux, J., Espil-Taris, C., Gousse, G., Gitiaux, C., Lambert, C., Laroche, C., Laugel, V., Moing, A. L., Pereon, Y., …, & Sarret, C. (2025). Evaluation of professional practices in the use of mexiletine for the management of childhood myotonia in French pediatric neuromuscular centers (MEXI-PEDI survey). Archives de Pédiatrie. https://doi.org/10.1016/j.arcped.2024.10.009
Vancouver
Barrière S, Manel V, Barnerias C, Wahbi K, Audic F, Cances C, et al. Evaluation of professional practices in the use of mexiletine for the management of childhood myotonia in French pediatric neuromuscular centers (MEXI-PEDI survey). Archives de Pédiatrie. 2025. doi:10.1016/j.arcped.2024.10.009
BibTeX
@article{Barrire2025,
author = {Barrière, Sarah and Manel, Véronique and Barnerias, Christine and Wahbi, Karim and Audic, Frédérique and Cances, Claude and Chouchane, Mondher and Dabaj, Ivana and Davion, Jean-Baptiste and Desguerre, Isabelle and Durigneux, Julien and Espil-Taris, Caroline and Gousse, Gaelle and Gitiaux, Cyril and Lambert, Clémentine and Laroche, Cécile and Laugel, Vincent and Moing, Anne-Gaelle Le and Pereon, Yann and Quijano-Roy, Susana and Ropars, Juliette and Sarrazin, Elisabeth and Serrand, Benjamin and Thibaud, Marie and Trommsdorff, Valérie and Urtizberea, Jon Andoni and Vanhulle, Catherine and Walther-Louvier, Ulrike and Isapof, Arnaud and Sarret, Catherine},
title = {Evaluation of professional practices in the use of mexiletine for the management of childhood myotonia in French pediatric neuromuscular centers (MEXI-PEDI survey)},
journal = {Archives de Pédiatrie},
year = {2025},
doi = {10.1016/j.arcped.2024.10.009}
}
EUVIMED